Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism

Dick C Chan, Gerald F Watts, Ransi Somaratne, Scott M Wasserman, Rob Scott, P Hugh R Barrett

Research output: Contribution to journalArticlepeer-review

21 Citations (Web of Science)

Fingerprint

Dive into the research topics of 'Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism'. Together they form a unique fingerprint.

Medicine & Life Sciences